V. Reus

发表

Contribution of common and rare variants to bipolar disorder susceptibility in extended pedigrees from population isolates

C. Sabatti, N. Freimer, R. Ophoff, 2018, bioRxiv.

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response

R B Altman, D M Roden, H L McLeod, 2007, Clinical pharmacology and therapeutics.

Faculty Opinions recommendation of Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.

V. Reus, 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

in leukocyte transcriptional control pathway associated with major depressive disorder and antidepressant treatment.

V. Reus, D. Stamatiou, M. Schonemann, 2016 .

Analysis of diagnosis instability in electronic health records reveals diverse disease trajectories of severe mental illness

A. Bui, C. López-Jaramillo, N. Freimer, 2022, medRxiv.

Geospatial analysis reveals distinct hotspots of severe mental illness

C. Sabatti, R. Gur, T. Teshiba, 2022, medRxiv.

An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia

M. McCarthy, N. Freimer, G. Bedoya, 2000, Neuroscience Letters.

Therapeutic Drug Monitoring of Nortriptyline in Smoking Cessation: A Multistudy Analysis

S. Hall, R. Muñoz, K. Delucchi, 2008, Clinical pharmacology and therapeutics.

Characterization of expression quantitative trait loci in extensively phenotyped pedigrees ascertained for bipolar disorder

C. Sabatti, N. Freimer, Y. Benjamini, 2015, bioRxiv.